Evidence map›Paper›PMID 40358441›Full record

ArticlePediatric blood & cancer2025

Patient Characteristics and Neighborhood-Level Social Determinants of Health Associated With Childhood Cancer Survivor Follow-Up at Urban Cancer Centers.

Tara K Suntum, Jaeil Ahn, Tania Lobo, Adil Alaoui, Burton E Appel, Caileigh Pudela, Leah Beight, Claudia Heller, Stacy L Bryant, Kenneth P Tercyak and 3 more

Abstract read
In one paragraph

Article in Pediatric blood & cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tara K SuntumGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.ORCID https://orcid.org/0000-0003-2700-0695
Jaeil AhnGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Tania LoboGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Adil AlaouiInnovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, District of Columbia, USA.
Burton E AppelJoseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Caileigh PudelaGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Leah BeightGeorgetown University School of Medicine, Washington, District of Columbia, USA.
Claudia HellerJoseph M. Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, New Jersey, USA.
Stacy L BryantGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Kenneth P TercyakGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.ORCID https://orcid.org/0000-0003-0274-556X
Chiranjeev DashGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Arnold L PotoskyGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.
Nina S Kadan-LottickGeorgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI MARCUS S NOEL · 1990 to 2026
$71.5M
National Cancer Institute of the National Institutes of Health P30CA051008-28S2NCI NIH HHS P30 CA051008
6 · The paper itself

Abstract

backgroundMany childhood cancer survivors (CCS) do not receive long-term follow-up care. We investigated the association of patient characteristics and neighborhood-level social determinants of health (SDOH) with follow-up.

methodsCCS (N = 354) diagnosed 2013-2022 at age <18 years were identified from cancer registries at two urban hospitals. Demographics and cancer history were abstracted from the cancer registries, supplemented by electronic health record data. Vital status was ascertained from the National Death Index. Neighborhood-level SDOH was measured with social vulnerability index, childhood opportunity index, and area deprivation index. Outcomes included survivorship clinic attendance ≥ 2 years posttherapy and any ambulatory visit ≥3 and ≥5 years posttherapy at the hospitals.

resultsSurvivorship clinic attendance was 52% ≥2 years posttherapy. Nonattendance was associated with adolescent age at diagnosis (42% for 11-17 vs. 65% for 6-10 years; p = 0.012), non-Hispanic Black race and ethnicity versus non-Hispanic White (32 vs. 57%, p = 0.048), and central nervous system (CNS) versus hematologic cancer (19 vs. 54%, p = 0.0005). The frequency of any ambulatory visit declined from 60% ≥3 years posttherapy to 40% ≥5 years posttherapy. Although 60% of CNS cancer survivors remained in ambulatory follow-up ≥5 years posttherapy, only 19% attended survivorship clinic. In multivariate analyses, neighborhood-level SDOH measures were not associated with follow-up.

conclusionsThere was a substantial drop in follow-up among CCS from 3 to 5 years posttherapy. Future studies of follow-up should focus on engagement of CNS cancer survivors, patients diagnosed during adolescence, and minority groups.

Indexed as

Cancer Care FacilitiesCancer SurvivorsNeighborhood CharacteristicsNeoplasmsSocial Determinants of HealthAdolescentChildChild, PreschoolFemaleFollow-Up StudiesHumansInfantMalePrognosisRegistriesSurvival Ratechildhood cancer survivorshealthcare follow‐uphealth disparitiessocial determinants of healthsurvivorship clinic

Identifiers

PMID40358441
PMCPMC13019601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.